Barillo, Reah Camille .

HRN: 27-20-86  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/30/2025
CEFUROXIME 500MG (TAB)
05/30/2025
06/04/2025
PO
500mg
BID X 7 Days
UTI; RMLE
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines